About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 486 record(s)
Req # A-2022-001031
Adverse Drug Reaction (ADR) for Asaphen E.C. Report number: 000993038. Adverse Drug Reaction (ADR) for Asaphen E.C.: 000993038.Organization: Health Canada
November 2022
Req # A-2022-001118
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-115542-678.Organization: Health Canada
November 2022
Req # A-2016-000411
The reviewer’s comments and correspondence pertaining to the safety, efficacy, labelling and specifically the approval for Gynecare TVT abdominal Access system approved for use in Canada on January 4, 2002 on the transvaginal mesh products manufactured by Johnson & Johnson.Organization: Health Canada
November 2022
Req # A-2017-000117
All records relating to complaints received by Health Canada related to the product Dukoral.Organization: Health Canada
November 2022
Req # A-2018-000804
All correspondence related to Health Canada’s approval of sodium propionate and propionic acid as anti-bacterial preservatives for meat, as described in Food additives propionic acid and sodium propionate permitted in ready-to-eat meat and poultry meat products.Organization: Health Canada
November 2022
Req # A-2018-000997
All cover letters and tables of contents with respect to the comprehensive summary section of the new drug submission for glatiramer acetate (tradename: COPAXONE, New Drug Submission (NDS) 044430, received 1996-07-12), Notice of Compliance date 1997-09-04.Organization: Health Canada
November 2022
Req # A-2018-001453
All documents regarding Re-evaluation Note REV2007-03 - Update on the Re-evaluation of Strychnine from January 1, 2005 to December 31, 2007.Organization: Health Canada
November 2022
Req # A-2018-001494
All draft and final Briefing Notes to Minister related to the preparation and consideration of policies and draft legislation leading up to the passage of the Canada Health Act for the years 1980-1985.Organization: Health Canada
November 2022
Req # A-2018-001625
In March 2018, and in the Fall of 2018, patients at the Duval Clinic in Laval Quebec received an osseointegrated implant also known as a bone-anchored prosthesis. The devices were approved under the custom device approval process. Documents requesting that approval and also any report or assessment performed by Health Canada staff that led to the custom device approval.Organization: Health Canada
November 2022
Req # A-2019-002035
All documents regarding the issuing and promotion of the following tweet (https://twitter.com/GovCanHealth/status/1233423150400053248), including any information on how long it was sponsored/promoted on Twitter.Organization: Health Canada
November 2022